-
-
-
-
-
-
-
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
-
-
-
-
-
-
Compass Pathways (CMPS) PT Raised to $14 at Stifel
-
-
-
-
-
-
-
Compass Pathways Successfully Achieves Primary Endpoint in Second Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression
-
-
-
-
-
-
-
Compass Pathways to Announce Third Quarter Financial Results on November 4, 2025
-
-
-
-
-
-
-
Compass Pathways to Announce First Quarter Financial Results on May 8, 2025
-
-
-
-
-
-
-
Compass Pathways (CMPS) PT Lowered to $18 at RBC Capital
-
-
-
-
-
-
-
Compass Pathways Announces First Quarter 2024 Financial Results and Business Highlights
-
1,231,057 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


